Review the Evidence for Structured Education in Diabetes Management

2021 ◽  
Vol 1 (1) ◽  
Author(s):  
Sumon Rahman Chowdhury
Keyword(s):  
Quality Of Life ◽  
Patient Satisfaction ◽  
Cost Effectiveness ◽  
Total Cholesterol ◽  
Diabetes Management ◽  
Diabetic Patients ◽  
Medical Outcomes ◽  
Education Programs ◽  
Structured Education

Structured Education is of detrimental importance for the management, counseling, and prevention of complications in diabetic patients. Different structured education programs exist that significantly improves the quality of life in diabetic patients as well as improves psychosocial outcomes by enhancing self-empowerment and self-motivation. Improvements have also been noted in bio-medical outcomes as a result of structured education most significantly in HbA1C, total cholesterol and frequency of hypoglycemia. In order to ensure patient satisfaction and improve outcomes related to complications, it is very important to identify and support patients whose psychosocial situations and reactions to the diagnosis may affect their ability to adjust or take adequate responsibility for self-care early in the course of the disease. In this review, we will discuss and highlight the evidence that support the benefits, limitations, and cost effectiveness of structured education in diabetes management.

scholarly journals Distress and Quality of Life among Type II Diabetic Patients: Role of physical activity

2021 ◽  
Vol 16 (1) ◽  
pp. 64-74
Author(s):  
Devaraju Kadari ◽  
Gadiraju Padmaja ◽  
Binod Rajak
Keyword(s):  
Quality Of Life ◽  
Physical Activity ◽  
Diabetes Management ◽  
Diabetic Patients ◽  
Type Ii ◽  
Snowball Sampling ◽  
Type Ii Diabetics ◽  
Group 2 ◽  
Group 1

This study measures the distress and Quality of Life (QoL) among people with type II diabetics in relation to physical exercise.  The study was conducted using diabetic participants chosen from various hospitals, aerobic centres, playgrounds and gyms in the city of Hyderabad in India.  The participants were divided into two groups – group 1 comprising people who did not adopt physical activity as part of their diabetes management strategy and group 2 comprising people who engaged in physical activity. A quasi-experimental study was performed on both groups employing purposive and snowball sampling methods. Pearson r showed that distress is negatively correlated with QoL among type II diabetics in both groups. Independent t-test indicated that participants in group 2 showed better QoL and lower levels of distress compared to their counterparts in group 1.

scholarly journals Original article. Cost-effectiveness of annual microalbuminuria screening in Thai diabetics

2014 ◽  
Vol 8 (3) ◽  
pp. 371-379 ◽  
Author(s):  
Attasit Srisubat ◽  
Jiruth Sriratanaban ◽  
Sureerat Ngamkiatphaisan ◽  
Kriang Tungsanga
Keyword(s):  
Quality Of Life ◽  
Diabetic Nephropathy ◽  
Cost Effectiveness ◽  
World Health ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
The Cost ◽  
Type 2 Diabetic

Abstract Background: Diabetes is a leading cause of end stage renal disease (ESRD), which impacts on treatment costs and patients’ quality of life. Microalbuminuria screening in patients with diabetes as an early intervention is beneficial in slowing the progression of diabetic nephropathy. Objectives: We aimed to assess the cost-effectiveness of annual microalbuminuria screening in type 2 diabetic patients. Methods: We compared screening by urine dipsticks with a “do nothing” scenario. To replicate the natural history of diabetic nephropathy, a Markov model based on a simulated cohort of 10,000 45-year-old normotensive diabetic patients was utilized. We calculated the cost and quality of life gathered from a cross-sectional survey. The costs of dialysis were derived from The National Health Security Office (NHSO). We also calculated the incremental cost-effectiveness ratio (ICER) for lifetime with a future discount rate of 3%. Results: The ICER was 3,035 THB per quality-adjusted life year (QALY) gained. One-way and probabilistic sensitivity analyses showed that all ICERs were less than the Thai Gross Domestic Product (GDP) per capita (150,000 THB in 2011) based on World Health Organization’s suggested criteria. Conclusions: Annual microalbuminuria screening using urine dipsticks in type 2 diabetic patients is very costeffective in Thailand based on World Health Organization’s recommendations. This finding has corroborated the benefit of this screening in the public health benefit package.

scholarly journals Diabetic Patients’ Quality of Life and Their Relationship in Compliance with Antidiabetic Treatment. Case Study of Patients in a Public Hospital in Greece

2020 ◽  
Vol 17 ◽  
Keyword(s):  
Quality Of Life ◽  
Type 2 Diabetes ◽  
Diabetes Management ◽  
Medical Science ◽  
Diabetic Patients ◽  
Adherence To Treatment ◽  
Adherence To Medication ◽  
Antidiabetic Treatment

Background & Aim: Diabetes is a chronic disease that affects nearly half a million people worldwide. Although advances in technology and medical science have made diabetes management easier today, self-care and adherence to treatment (medication, diet, exercise, etc.) remain a major challenge for diabetic patients. The purpose of this study is to study the quality of life of patients with type 2 diabetes, their levels of compliance with antidiabetic treatment, and the relationship between the two. Methods & Materials: The present work followed the quantitative approach. A well-structured and reliable questionnaire used in a previous study was distributed to patients with type 2 diabetes mellitus. The results were analysed in SPSS statistical program and the correlation between antidiabetic treatment and quality of life was examined using Pearson coefficient. Results: The study involved 165 patients with type 2 diabetes who were hospitalized at the General Hospital of Messinia. Among the dimensions of adherence to treatment, only personal care behaviour (p <0.05) and adherence to care (p <0.05) were significantly and positively correlated with the physical quality of life health. Conclusion: Patients with type 2 diabetes have moderate the low quality of life, in line with previous research findings. Lower extremity care compliance was associated with the quality of life of diabetic patients with physical health, although previous studies have generally found that compliance with a diet regimen as well as adherence to medication is associated with the quality of life of diabetic patients. Future research needs to address the same issue by taking larger and more representative samples.

Functional outcomes of trigger finger release in non-diabetic and diabetic patients

2020 ◽  
Vol 45 (10) ◽  
pp. 1078-1082
Author(s):  
Paul H. C. Stirling ◽  
Paul J. Jenkins ◽  
Andrew D. Duckworth ◽  
Nicholas D. Clement ◽  
Jane E. McEachan
Keyword(s):  
Quality Of Life ◽  
Patient Satisfaction ◽  
Functional Outcomes ◽  
Trigger Finger ◽  
Diabetic Patients ◽  
Health Related Quality ◽  
Related Quality ◽  
Health Related ◽  
A1 Pulley

We compared the functional outcomes, health-related quality of life, and satisfaction in diabetic and non-diabetic patients undergoing A1 pulley release for trigger finger in 192 patients. Preoperative and postoperative Quick Disabilities of the Arm, Shoulder and Hand questionnaire (Quick DASH), EuroQol-5 dimensions, and satisfaction scores were collected prospectively over a 6-year period. These patients had a mean follow-up of 14 months (range 11–40) after surgery. There were 143 patients (143 trigger fingers) without diabetes and 49 patients (49 trigger fingers) with diabetes. We found overall QuickDASH improvement was the same in both groups (–4.5 points). Patient satisfaction rates were comparable in both groups (90% versus 96%), and no significant difference in postoperative health-related quality of life was observed. No complications were reported in either group. We conclude from this study that A1 pulley release leads to similar functional improvement and high patient satisfaction at one year postoperatively in diabetic and non-diabetic patients. Level of evidence: III

scholarly journals Comparing Quality of Life in Type 2 Diabetic Patients Using Dulaglutide and Liraglutide

2021 ◽  
Vol 5 (Supplement_1) ◽  
pp. A468-A468
Author(s):  
Aneesh Ghosh
Keyword(s):  
Quality Of Life ◽  
Diabetes Mellitus ◽  
Diabetes Management ◽  
Diabetes Control ◽  
Value Systems ◽  
Diabetic Patients ◽  
Patient Centered ◽  
Oral Hypoglycaemic Agents

Abstract Background and Aims: WHO has defined quality of life as individuals perceptions of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns. The quality of life evaluation is seen as an important aspect of care of diabetes mellitus 1. In this context it is imperative to study how new agents will affect the quality of life. In this study we have compared the quality of life of patients using dulaglutide and liraglutide. Deign and Method: We have used a simple self-administered patient centered quality of life (PCQoL) measure that is based on general and diabetes related life. This tool has shown to strongly correlate with the established reference scorings system, diabetes related quality of life (DQoL) score, developed for the Diabetes Control and Complications Trial 2,3. Sixty eligible patients on oral hypoglycaemic agents and Dulaglutide (N:30) or Liraglutide (N:30) formed the study group. All study subjects were on steady dose of GLP 1 RA for at least six months before they took two part quality of life (general and diabetes related) questionnaire during their hospital visit. In each part, subjects nominated five facets of life, judged to be important to them for quality of life (most important rated 5). Each aspect was then weighted by the patient for their current level of satisfaction on a five-point Likert scale (5, completely satisfied; 1, not at all satisfied), and a total score was calculated. Groups were matched for for age, sex, diabetes duration, comorbidities and HbA1C. The means were compared with Student’s t test. Results: The quality of life scores were better for dulaglutide than for liraglutide treated subjects (mean [SD] PCQoL: 66 [61–70] vs 56 [52 - 60], p &lt; 0.05). Discussion: In the diabetes management strategy, a primary therapeutic goal is to address and better the quality of life. In this study we have established that once weekly Dulaglutide offers better quality of life than daily injections of Liraglutide. PCQoL is a patient centered quality of life measurement is quick, simple, repeatable, sensitive, and valid in type 2 diabetes mellitus. References: 1.Rubin R, Peyrot M. Quality of life and diabetes. Diab Metab Res Rev. 1999;15(3):205–18. 2.Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes. N Engl J Med. 1993;329(14):977–86. 3.John C. Pickup, Anna Harris. Assessing Quality of Life for New Diabetes Treatments and Technologies: A Simple Patient-Centered Score. Journal of Diabetes Science and Technology. 2007;1(3):394–99.

scholarly journals Use of Smart Technology for the Early Diagnosis of Complications After Cardiac Surgery: The Box 2.0 Study Protocol

10.2196/16326 ◽  
2020 ◽  
Vol 9 (4) ◽  
pp. e16326 ◽  
Author(s):  
Tom E Biersteker ◽  
Mark J Boogers ◽  
Robert AF de Lind van Wijngaarden ◽  
Rolf HH Groenwold ◽  
Serge A Trines ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cardiac Surgery ◽  
Patient Satisfaction ◽  
Cost Effectiveness ◽  
Early Detection ◽  
Wound Infection ◽  
Detection Rate ◽  
Sternal Wound Infection ◽  
Cardiac Decompensation

Background Atrial fibrillation (AF), sternal wound infection, and cardiac decompensation are complications that can occur after cardiac surgery. Early detection of these complications is clinically relevant, as early treatment is associated with better clinical outcomes. Remote monitoring with the use of a smartphone (mobile health [mHealth]) might improve the early detection of complications after cardiac surgery. Objective The primary aim of this study is to compare the detection rate of AF diagnosed with an mHealth solution to the detection rate of AF diagnosed with standard care. Secondary objectives include detection of sternal wound infection and cardiac decompensation, as well as assessment of quality of life, patient satisfaction, and cost-effectiveness. Methods The Box 2.0 is a study with a prospective intervention group and a historical control group for comparison. Patients undergoing cardiac surgery at Leiden University Medical Center are eligible for enrollment. In this study, 365 historical patients will be used as controls and 365 other participants will be asked to receive either The Box 2.0 intervention consisting of seven home measurement devices along with a video consultation 2 weeks after discharge or standard cardiac care for 3 months. Patient information will be analyzed according to the intention-to-treat principle. The Box 2.0 devices include a blood pressure monitor, thermometer, weight scale, step count watch, single-lead electrocardiogram (ECG) device, 12-lead ECG device, and pulse oximeter. Results The study started in November 2018. The primary outcome of this study is the detection rate of AF in both groups. Quality of life is measured with the five-level EuroQol five-dimension (EQ-5D-5L) questionnaire. Cost-effectiveness is calculated from a society perspective using prices from Dutch costing guidelines and quality of life data from the study. In the historical cohort, 93.9% (336/358) completed the EQ-5D-5L and patient satisfaction questionnaires 3 months after cardiac surgery. Conclusions The rationale and design of a study to investigate mHealth devices in postoperative cardiac surgery patients are presented. The first results are expected in September 2020. Trial Registration ClinicalTrials.gov NCT03690492; http://clinicaltrials.gov/show/NCT03690492 International Registered Report Identifier (IRRID) DERR1-10.2196/16326

scholarly journals Use of Smart Technology for the Early Diagnosis of Complications After Cardiac Surgery: The Box 2.0 Study Protocol (Preprint)

2019 ◽  
Author(s):  
Tom E Biersteker ◽  
Mark J Boogers ◽  
Robert AF de Lind van Wijngaarden ◽  
Rolf HH Groenwold ◽  
Serge A Trines ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cardiac Surgery ◽  
Patient Satisfaction ◽  
Cost Effectiveness ◽  
Early Detection ◽  
Wound Infection ◽  
Detection Rate ◽  
Sternal Wound Infection ◽  
Cardiac Decompensation

BACKGROUND Atrial fibrillation (AF), sternal wound infection, and cardiac decompensation are complications that can occur after cardiac surgery. Early detection of these complications is clinically relevant, as early treatment is associated with better clinical outcomes. Remote monitoring with the use of a smartphone (mobile health [mHealth]) might improve the early detection of complications after cardiac surgery. OBJECTIVE The primary aim of this study is to compare the detection rate of AF diagnosed with an mHealth solution to the detection rate of AF diagnosed with standard care. Secondary objectives include detection of sternal wound infection and cardiac decompensation, as well as assessment of quality of life, patient satisfaction, and cost-effectiveness. METHODS <i>The Box 2.0</i> is a study with a prospective intervention group and a historical control group for comparison. Patients undergoing cardiac surgery at Leiden University Medical Center are eligible for enrollment. In this study, 365 historical patients will be used as controls and 365 other participants will be asked to receive either <i>The Box 2.0</i> intervention consisting of seven home measurement devices along with a video consultation 2 weeks after discharge or standard cardiac care for 3 months. Patient information will be analyzed according to the intention-to-treat principle. <i>The Box 2.0</i> devices include a blood pressure monitor, thermometer, weight scale, step count watch, single-lead electrocardiogram (ECG) device, 12-lead ECG device, and pulse oximeter. RESULTS The study started in November 2018. The primary outcome of this study is the detection rate of AF in both groups. Quality of life is measured with the five-level EuroQol five-dimension (EQ-5D-5L) questionnaire. Cost-effectiveness is calculated from a society perspective using prices from Dutch costing guidelines and quality of life data from the study. In the historical cohort, 93.9% (336/358) completed the EQ-5D-5L and patient satisfaction questionnaires 3 months after cardiac surgery. CONCLUSIONS The rationale and design of a study to investigate mHealth devices in postoperative cardiac surgery patients are presented. The first results are expected in September 2020. CLINICALTRIAL ClinicalTrials.gov NCT03690492; http://clinicaltrials.gov/show/NCT03690492 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/16326

72: Quality of Life and Patient Satisfaction of Care Among Women with Urinary Incontinence: A Prospective Study

2007 ◽  
Vol 177 (4S) ◽  
pp. 25-26
Author(s):  
Simon Kim ◽  
Rodney L. Dunn ◽  
Edward J. McGuire ◽  
John O.L. DeLancey ◽  
John T. Wei
Keyword(s):  
Quality Of Life ◽  
Urinary Incontinence ◽  
Patient Satisfaction ◽  
Prospective Study ◽  
A Prospective Study
Sign in / Sign up

Export Citation Format

Share Document